<DOC>
	<DOCNO>NCT01434914</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled trial octenisept® placebo patient chronic leg ulcer . The study conduct single center total 70 patient . Patients randomize either octenisept® group placebo group .</brief_summary>
	<brief_title>Study Evaluate Efficacy Octenisept® Patients With Chronic Wounds</brief_title>
	<detailed_description>Randomized , double-blind , placebo-controlled trial octenisept® placebo patient chronic leg ulcer . The study conduct single center total 70 patient . Patients randomize either octenisept® group placebo group . Primary Objectives : Antimicrobial efficacy octenisept® compare placebo . Secondary Objectives : Subjective tolerance octenisept® , evaluation wound parameter .</detailed_description>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Octenidine</mesh_term>
	<criteria>Male female patient least 18 year time consent Patients venous leg ulcer ( Ulcus cruris ) Patients chronic leg ulcer Females childbearing potential willing comply applicable contraceptive requirement protocol Negative pregnancy test Satisfactory medical assessment Ability provide write informed consent Signed declaration consent Willingness cooperate Pregnant lactate woman woman use contraception Known history alcohol drug abuse Use antibiotic medication within last 7 day prior first dose Patients serious concomitant disease Patients coagulation disorder Known history allergic reaction attribute octenisept® one compound Participation another clinical trial within last 30 day randomization Concomitant treatment preparation interfere trial preparation disease Absence declaration consent Doubt willingness cooperate Nonfulfilment inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Ulcus cruris</keyword>
	<keyword>chronic wound</keyword>
	<keyword>octenisept®</keyword>
</DOC>